TY - CHAP M1 - Book, Section TI - Cannabinoid Drugs A1 - Vanderah, Todd W. A2 - Katzung, Bertram G. A2 - Vanderah, Todd W. PY - 2021 T2 - Basic & Clinical Pharmacology, 15e AB - CASE STUDYA 42-year-old woman with metastatic breast cancer being treated with a combination of cyclophosphamide, doxorubicin, and fluorouracil (5-FU) complains of pain due to chemotherapy-induced peripheral neuropathy. She has been unwilling to eat due to nausea and vomiting induced by her medications. She is receiving heavy doses of oxycodone for pain, but this has resulted in severe constipation. Upon her visit with the oncologist she shows physical signs of cachexia and reports ongoing pain in her back and hips. Friends suggest medical marijuana as a strategy for controlling her present symptoms. What evidence supports this approach? What might be the unwanted effects of this strategy? SN - PB - McGraw-Hill CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1176472395 ER -